September 17, 2024 02:51 PM EDT

Conducting trials via routine clinical practice: FDA explains how in new draft guidance

Zachary Brennan

Senior Editor

The FDA on Tuesday firmed up its position that in some limited circumstances, clinical trial data may be obtained from routine clinical practice. The use …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Conducting trials via routine clinical practice: FDA explains how in new draft guidance

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Here's what today's Fed rate cut means for biotech, pharma and venture capital

FDA cancels Applied Therapeutics adcomm, shares skyrocket 65%

All of 23andMe's independent board members resign over disagreements with CEO

You bet your life: After I was diagnosed with a rare cancer, I discovered how a small band of physician-scientists ...

With few efficacy details, Insilico claims a Phase 2a win in latest AI readout

Breaking down silos with a new quantitative approach to drug development

Con­duct­ing tri­als via rou­tine clin­i­cal prac­tice: FDA ex­plains how in new draft guid­ance

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Conducting trials via routine clinical practice: FDA explains how in new draft guidance